P450 Monooxygenases Enable Rapid Late‐Stage Diversification of Natural Products via C−H Bond Activation
Open Access
- 22 January 2019
- journal article
- review article
- Published by Wiley in ChemCatChem
- Vol. 11 (9) , 2226-2242
Abstract
The biological potency of natural products has been exploited for decades. Their inherent structural complexity and natural diversity might hold the key to efficiently address the urgent need for the development of novel pharmaceuticals. At the same time, it is that very complexity, which impedes necessary chemical modifications such as structural diversification, to improve the effectiveness of the drug. For this purpose, Cytochrome P450 enzymes, which possess unique abilities to activate inert sp3‐hybridised C−H bonds in a late‐stage fashion, offer an attractive synthetic tool. In this review the potential of cytochrome P450 enzymes in chemoenzymatic lead diversification is illustrated discussing studies reporting late‐stage functionalisations of natural products and other high‐value compounds. These enzymes were proven to extend the synthetic toolbox significantly by adding to the flexibility and efficacy of synthetic strategies of natural product chemists, and scientists of other related disciplines.Keywords
Funding Information
- European Union's Horizon 2020 research and innovation programme
- OXYtrain MSCA-ITN (722390)
This publication has 178 references indexed in Scilit:
- Macrocyclic Drugs and Synthetic Methodologies toward MacrocyclesMolecules, 2013
- Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11JBIC Journal of Biological Inorganic Chemistry, 2011
- Enzyme-mediated oxidations for the chemistGreen Chemistry, 2010
- Privileged scaffolds for library design and drug discoveryCurrent Opinion in Chemical Biology, 2010
- Selective oxidation of carbolide C–H bonds by an engineered macrolide P450 mono-oxygenaseProceedings of the National Academy of Sciences, 2009
- A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead CompoundsChemistry – A European Journal, 2009
- The economies of synthesisChemical Society Reviews, 2009
- QM/MM Simulation on P450 BM3 Enzyme Catalysis MechanismJournal of Chemical Theory and Computation, 2009
- Natural Products as a Robust Source of New Drugs and Drug Leads: Past Successes and Present Day IssuesThe American Journal of Cardiology, 2008
- Engineering and Analysis of a Self-Sufficient Biosynthetic Cytochrome P450 PikC Fused to the RhFRED Reductase DomainJournal of the American Chemical Society, 2007